SFL is participating in the BIO Digital International Convention

SFL supported first Swiss approval of an oncology drug in line with US FDA’s Project Orbis; an initiative for concurrent submission and review of oncology drug applications by US FDA and international regulatory agencies

SFL to participate in EU pharma and medical device law conference

Brexit goes real – What’s next for Pharma and Medtech